HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Payton, M. Articles by Sim, E. Search for Related Content PubMed PubMed Citation Articles by Payton, M. Articles by Sim, E. Agricola Articles by Payton, M. Articles by Sim, E.

Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis

University Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK¹

Author for correspondence: Edith Sim. Tel: +44 1865 271850. Fax: +44 1865 271853. e-mail: esim{at}molbiol.ox.ac.uk

Arylamine N-acetyltransferase (NAT) in humans inactivates the anti-tubercular drug isoniazid (INH). Homologues of human NAT are present in Mycobacterium tuberculosis and Mycobacterium smegmatis, where they can acetylate, and hence inactivate, INH. The in vivo role of mycobacterial NAT is not known but heterologous expression of the M. tuberculosis gene increases the INH resistance. The 0·85 kb nat gene is part of a gene cluster in M. smegmatis. The gene is transcribed as a large, 7·5 kb mRNA as demonstrated by Northern analysis. A nat knockout strain of M. smegmatis was generated by targeted disruption. The new strain was confirmed to be devoid of NAT activity. The growth of the knockout strain is considerably delayed compared with the wild-type, due to an extended lag phase. The knockout mutant has an increased sensitivity to INH as would be predicted. The NATs from M. smegmatis and M. tuberculosis have a high degree of homology, except in the region of the C terminus. A specific polyclonal antiserum raised against recombinant NAT protein from M. tuberculosis is described that recognizes a stretch of about twenty residues within the C terminus of M. tuberculosis NAT. This highly specific antiserum will enable comparison of nat expression between isolates of M. tuberculosis.

Keywords: mycobacteria, knockout, immunogenic, antibacterial, tuberculosis

Abbreviations: NAT, arylamine N-acetyltransferase; INH, isoniazid

This article has been cited by other articles:

				H. Suzuki, Y. Ohnishi, and S. Horinouchi Arylamine N-Acetyltransferase Responsible for Acetylation of 2-Aminophenols in Streptomyces griseus J. Bacteriol., March 1, 2007; 189(5): 2155 - 2159. [Abstract] [Full Text] [PDF]

				C. Sholto-Douglas-Vernon, J. Sandy, T. C Victor, E. Sim, and P. D. Helden Mutational and expression analysis of tbnat and its response to isoniazid J. Med. Microbiol., December 1, 2005; 54(12): 1189 - 1197. [Abstract] [Full Text] [PDF]

				J. Sandy, S. Holton, E. Fullam, E. Sim, and M. Noble Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis Protein Sci., March 1, 2005; 14(3): 775 - 782. [Abstract] [Full Text] [PDF]

				S. Bhakta, G. S. Besra, A. M. Upton, T. Parish, C. Sholto-Douglas-Vernon, K. J.C. Gibson, S. Knutton, S. Gordon, R. P. daSilva, M. C. Anderton, et al. Arylamine N-Acetyltransferase Is Required for Synthesis of Mycolic Acids and Complex Lipids in Mycobacterium bovis BCG and Represents a Novel Drug Target J. Exp. Med., May 3, 2004; 199(9): 1191 - 1199. [Abstract] [Full Text] [PDF]